Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CCNT1 | O60563 | 3/20 | 0.41 |
| ▸ | CDK9 | P50750 | 3/20 | 0.41 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12892630 | 0.96 | TAAR1 (0.49) | TAAR1L3MBTL1TSHRCCNT1CDK9 | |
| SCHEMBL12215858 | 0.93 | TAAR1 (0.39) | TAAR1L3MBTL1TSHRCCNT1CDK9 | |
| SCHEMBL13904866 | 0.86 | CCNT1 (0.35) | TAAR1L3MBTL1TSHRCCNT1CDK9 | |
| SCHEMBL6298899 | 0.85 | EGFR (0.43) | L3MBTL1TSHRCCNT1CDK9EGFR | |
| SCHEMBL13018894 | 0.83 | CCNT1 (0.44) | L3MBTL1CCNT1CDK9EGFRMAPT | |
| SCHEMBL15515807 | 0.83 | HTR2A (0.40) | L3MBTL1TSHRCCNT1CDK9EGFR | |
| SCHEMBL23525666 | 0.82 | CCNT1 (0.39) | L3MBTL1CCNT1CDK9EGFRMAPT | |
| SCHEMBL30791331 | 0.82 | CCNT1 (0.39) | L3MBTL1CCNT1CDK9EGFRMAPT | |
| SCHEMBL23364293 | 0.82 | KDM4E (0.44) | L3MBTL1TSHRMAPTHTT | |
| SCHEMBL11070999 | 0.82 | LMNA (0.41) | L3MBTL1CCNT1CDK9EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100221180-A1 | IN VIVO IMAGING OF MYELINATION | WANG YANMING | 2010-09-02 | — | — | US | disclosed |
| US-20100221180-A1 | IN VIVO IMAGING OF MYELINATION | WANG YANMING | 2010-09-02 | — | — | US | disclosed |
| US-20100207078-A1 | DEPROTECTION OF FUNCTIONAL GROUPS BY MULTI-PHOTON INDUCED ELECTRON TRANSFER | THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2010-08-19 | — | — | US | disclosed |
| US-20100207078-A1 | DEPROTECTION OF FUNCTIONAL GROUPS BY MULTI-PHOTON INDUCED ELECTRON TRANSFER | THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2010-08-19 | — | — | US | disclosed |
| US-7718760-B2 | π-Conjugated polymer and manufacturing method thereof | RICOH COMPANY, LTD. (JP) | 2010-05-18 | — | — | US | disclosed |
| US-20090218564-A1 | Alternating copolymers of phenylene vinylene and biarylene vinylene, preparation method thereof, and organic thin flim transister comprising the same | SAMSUNG ELECTRONICS CO., LTD. | 2009-09-03 | — | — | US | disclosed |
| US-7550554-B2 | Aryl amine polymer, thin film transistor using the new aryl amine polymer, and method of manufacturing the thin film transistor | RICOH COMPANY, LTD. (JP) | 2009-06-23 | — | — | US | disclosed |
| WO-2009029936-A1 | IN VIVO IMAGING OF MYELIN | CASE WESTERN RESERVE UNIVERSITY (US) | 2009-03-05 | — | — | WO | disclosed |
| WO-2008008481-A2 | DEPROTECTION OF FUNCTIONAL GROUPS BY MULTI-PHOTON INDUCED ELECTRON TRANSFER | GEORGIA TECH RESEARCH CORPORATION (US) | 2008-01-17 | — | — | WO | disclosed |
| US-20070092760-A1 | NEW ARYL AMINE POLYMER, THIN FILM TRANSISTOR USING THE NEW ARYL AMINE POLYMER, AND METHOD OF MANUFACTURING THE THIN FILM TRANSISTOR | SAGISAKA TOSHIYA | 2007-04-26 | — | — | US | disclosed |
| US-7166689-B2 | Aryl amine polymer, thin film transistor using the aryl amine polymer, and method of manufacturing the thin film transistor | RICOH COMPANY, LTD. (JP) | 2007-01-23 | — | — | US | disclosed |
| US-6316591-B1 | FOR USE IN LIGHTING OR DISPLAY DEVICES; SOLID-STATE LIGHT SOURCES | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 2001-11-13 | — | — | US | disclosed |
| US-5814244-A | POLYARYLENEVINYLENES, LOW THRESHOLD VOLTAGE AND HIGH EFFICIENCY | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100221180-A1 | IN VIVO IMAGING OF MYELINATION | MAG, PMP22, MYT1 | TAAR1 837/4885L3MBTL1 1202/4885TSHR 4529/4885 |
| US-20100207078-A1 | DEPROTECTION OF FUNCTIONAL GROUPS BY MULTI-PHOTON INDUCED ELECTRON TRANSFER | GPX4, ERCC4, CYBA | TAAR1 4863/4885L3MBTL1 1826/4885TSHR 4825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.